Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter
You have a filtered search result

51 search results for ‘*’

Tools & Techniques Omics

A Microbial Map to Cancer

| Michael Schubert

A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.

Disease Area Metabolism & Diabetes

Tackling the Fatty-Liver Timebomb

| Jonathan James

Could modulation of fibroblast growth factor 21 translate into a new treatment for non-alcoholic fatty liver disease?

Tools & Techniques Imaging

IVF ID

| Jonathan James

Artificial intelligence holds the key to improving embryo selection for in vitro fertilization.

Outside the Lab Public health

Picking up on the Subtler Signs of Brain Cancer

| Jonathan James

How early telltales of tumors are frequently missed by both patients and clinicians

Research Field Nanomedicine

Rewriting the Cancer Code

| Jonathan James

Scientists are targeting cancer’s “housekeeping” genes with biological nanomachines

Disease Area Cancer

Proving the worth of ICIs

| Jonathan James

New evidence points to the safety – and benefits – of immune checkpoint therapy in HIV-positive cancer patients

Tools & Techniques Drug delivery

Next Steps for the Self-Righting Insulin Pill

| Jonathan James

Will diabetes treatment be revolutionized by the drug delivery capsule inspired by the geometry of the leopard tortoise?

Research Field Neurological

Redirecting Cell Fate

| Jonathan James

A chemical cocktail of small molecules shows promise in driving neuro-regeneration.

Tools & Techniques Cancer

Circular RNA Makes Its Mark

| Jason Sherburn

A new detection method enhances circular RNA’s potential as a cancer biomarker and forms the basis of a new database

Tools & Techniques Diagnostics & prognostics

A Nose for Cancer

| Jonathan James

Could a multi-layer graphene (MLG)-based biomarker sensor offer the sensitivity needed for earlier lung cancer detection?

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register